Terms: = Leukemia AND RHOH, TTF, 399, ENSG00000168421, ARHH, RhoH AND Treatment
69 results:
1. The association of environmental factors with neurocognitive outcomes in survivors of childhood acute lymphoblastic leukemia (ALL).
Nigro SE; Hall LP; Harman J; Willard VW; Conklin HM; Pui CH; Jeha S; Jacola LM
Support Care Cancer; 2023 Dec; 32(1):1. PubMed ID: 38047975
[TBL] [Abstract] [Full Text] [Related]
2. Spliceosome mutations are associated with clinical response in a phase 1b/2 study of the PLK1 inhibitor onvansertib in combination with decitabine in relapsed or refractory acute myeloid leukemia.
Croucher PJP; Ridinger M; Becker PS; Lin TL; Silberman SL; Wang ES; Zeidan AM
Ann Hematol; 2023 Nov; 102(11):3049-3059. PubMed ID: 37702821
[TBL] [Abstract] [Full Text] [Related]
3. Enasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed/refractory AML: a randomized phase 3 trial.
de Botton S; Montesinos P; Schuh AC; Papayannidis C; Vyas P; Wei AH; Ommen H; Semochkin S; Kim HJ; Larson RA; Koprivnikar J; Frankfurt O; Thol F; Chromik J; Byrne J; Pigneux A; Thomas X; Salamero O; Vidriales MB; Doronin V; Döhner H; Fathi AT; Laille E; Yu X; Hasan M; Martin-Regueira P; DiNardo CD
Blood; 2023 Jan; 141(2):156-167. PubMed ID: 35714312
[TBL] [Abstract] [Full Text] [Related]
4. Real-world treatment patterns and clinical outcomes in patients with AML unfit for first-line intensive chemotherapy
Miyamoto T; Sanford D; Tomuleasa C; Hsiao HH; Olivera LJE; Enjeti AK; Gimenez Conca A; Castillo TBD; Girshova L; Martelli MP; Guvenc B; Delgado A; Duan Y; Garbayo Guijarro B; Llamas C; Lee JH
Leuk Lymphoma; 2022 Apr; 63(4):928-938. PubMed ID: 35147482
[TBL] [Abstract] [Full Text] [Related]
5. Health care utilisation following childhood acute lymphoblastic leukaemia: a population-based matched cohort study.
Jensen KS; Klug Albertsen B; Schrøder H; Zalounina Falborg A; Schmiegelow K; Rosthøj S; Callesen MT; Vedsted P
BMJ Open; 2021 Nov; 11(11):e049847. PubMed ID: 34810184
[TBL] [Abstract] [Full Text] [Related]
6. Venetoclax plus low-dose cytarabine in Japanese patients with untreated acute myeloid leukaemia ineligible for intensive chemotherapy.
Yamauchi T; Yoshida C; Usuki K; Takada S; Matsumura I; Dobashi N; Miyazaki Y; Miyamoto T; Iida H; Asou N; Kuroda J; Ichikawa S; Komatsu N; Mendes W; Honda H; Okubo S; Kurokawa M; Jiang Q; Wei A; Ishizawa K
Jpn J Clin Oncol; 2021 Aug; 51(9):1372-1382. PubMed ID: 34322703
[TBL] [Abstract] [Full Text] [Related]
7. Cost-Effectiveness of Tisagenlecleucel in Paediatric Acute Lymphoblastic Leukaemia (pALL) and Adult Diffuse Large B-Cell Lymphoma (DLBCL) in Switzerland.
Moradi-Lakeh M; Yaghoubi M; Seitz P; Javanbakht M; Brock E
Adv Ther; 2021 Jun; 38(6):3427-3443. PubMed ID: 34021886
[TBL] [Abstract] [Full Text] [Related]
8. Fatigue Perpetuating Factors as Mediators of Change in a Cognitive Behavioral Intervention for Targeted Therapy-Related Fatigue in Chronic Myeloid leukemia: A Pilot Study.
Hyland KA; Nelson AM; Eisel SL; Hoogland AI; Ibarz-Pinilla J; Sweet K; Jacobsen PB; Knoop H; Jim HSL
Ann Behav Med; 2022 Feb; 56(2):137-145. PubMed ID: 33991085
[TBL] [Abstract] [Full Text] [Related]
9. Severe hypercalcemia in a patient with chronic lymphocytic leukemia and non-small cell lung carcinoma: A case report.
Shacham EC; Marshak DC; Brikman S; Dori G; Ishay A
Medicine (Baltimore); 2021 Apr; 100(14):e24982. PubMed ID: 33832072
[TBL] [Abstract] [Full Text] [Related]
10. Haploidentical hematopoietic stem cell transplantation for patients with myeloid sarcoma: a single center retrospective study.
Yu WJ; Sun YQ; Han TT; Ye PP; Zhang XH; Xu LP; Liu KY; Yan CH; Huang XJ; Wang Y
Ann Hematol; 2021 Mar; 100(3):799-808. PubMed ID: 33416901
[TBL] [Abstract] [Full Text] [Related]
11. [Erythrophagocytosis by blast cells and de novo T cell LAL without cytogenetic abnormalities in a Moroccan patient].
Kahouli S; Zahid H; Khorassani ME; Kabbaj SE; Benkirane M; Messaoudi N
Pan Afr Med J; 2020; 36():202. PubMed ID: 32963668
[TBL] [Abstract] [Full Text] [Related]
12. Electrocardiographic characteristics of diffuse large B-cell lymphoma patients treated with anthracycline-based chemotherapy.
Chen Z; Lu K; Zhou L; Liu D; Li X; Han X; Tao H; Tse G; Zhang H; Liu T
J Electrocardiol; 2020; 60():195-199. PubMed ID: 32413696
[TBL] [Abstract] [Full Text] [Related]
13. Levothyroxine treatment is associated with an increased relative risk of overall and organ specific incident cancers - a cohort study of the Swedish population.
Wändell P; Carlsson AC; Li X; Sundquist J; Sundquist K
Cancer Epidemiol; 2020 Jun; 66():101707. PubMed ID: 32222650
[TBL] [Abstract] [Full Text] [Related]
14. Phase I study of ibrutinib in Japanese patients with treatment-naïve chronic lymphocytic leukemia/small lymphocytic lymphoma.
Shibayama H; Teshima T; Choi I; Hatake K; Sekiguchi N; Yoshinari N
J Clin Exp Hematop; 2019; 59(4):179-186. PubMed ID: 31866619
[TBL] [Abstract] [Full Text] [Related]
15. Every-other-day palonosetron plus aprepitant for prevention of emesis following induction chemotherapy for acute myeloid leukemia: A randomized, controlled study from the "Rete Ematologica Pugliese".
Di Renzo N; Melillo L; Porretto F; Dargenio M; Pavone V; Pastore D; Mazza P; Mannina D; Merenda A; Cascavilla N; Greco G; Matera R; Bonizzoni E; Celio L; Musso M
Cancer Med; 2020 Jan; 9(1):170-178. PubMed ID: 31725196
[TBL] [Abstract] [Full Text] [Related]
16. Internet-assisted cognitive behavioral intervention for targeted therapy-related fatigue in chronic myeloid leukemia: Results from a pilot randomized trial.
Jim HSL; Hyland KA; Nelson AM; Pinilla-Ibarz J; Sweet K; Gielissen M; Bulls H; Hoogland AI; Jacobsen PB; Knoop H
Cancer; 2020 Jan; 126(1):174-180. PubMed ID: 31553815
[TBL] [Abstract] [Full Text] [Related]
17. Computer-Aided Discovery of Massonianoside B as a Novel Selective DOT1L Inhibitor.
Chen J; Park HJ
ACS Chem Biol; 2019 May; 14(5):873-881. PubMed ID: 30951287
[TBL] [Abstract] [Full Text] [Related]
18. Hematopoietic Cell Transplantation in Young Adult Acute Lymphoblastic leukemia: A United States Population-Level Analysis.
Muffly L; Li Q; Alvarez E; Kahn J; Winestone L; Cress R; Penn DC; Keegan THM
J Adolesc Young Adult Oncol; 2019 Jun; 8(3):254-261. PubMed ID: 30657424
[TBL] [Abstract] [Full Text] [Related]
19. Phase 2 trial of bortezomib in combination with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with bortezomib, rituximab, methotrexate, and cytarabine for untreated mantle cell lymphoma.
Romaguera JE; Wang M; Feng L; Fayad LE; Hagemeister F; McLaughlin P; Rodriguez MA; Fanale M; Orlowski R; Kwak LW; Neelapu S; Oki Y; Pro B; Younes A; Samaniego F; Fowler N; Hartig K; Valentinetti M; Smith J; Ford P; Naig A; Medeiros LJ; Kantarjian HM; Goy A
Cancer; 2018 Jun; 124(12):2561-2569. PubMed ID: 29723393
[TBL] [Abstract] [Full Text] [Related]
20. Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the treatment of Acute Lymphoblastic leukemia.
Magnani CF; Mezzanotte C; Cappuzzello C; Bardini M; Tettamanti S; Fazio G; Cooper LJN; Dastoli G; Cazzaniga G; Biondi A; Biagi E
Hum Gene Ther; 2018 May; 29(5):602-613. PubMed ID: 29641322
[TBL] [Abstract] [Full Text] [Related]
[Next]
